ABSTRACT: A patient with systemic lupus erythematosus after renal transplantation undergo pancreatoduodenectomy for pancreatic adenocarcinoma- A case report
Project description:Neuropsychiatric systemic lupus erythematosus (NPSLE) is a severe complication of systemic lupus erythematosus (SLE), characterized by heterogeneous neurological manifestations. Current therapies, such as plasma exchange (PE), are limited by cardiovascular risks and resource availability. This case report explores peritoneal dialysis (PD) as a novel dual-purpose therapy for NPSLE, combining renal support with immunomodulation. Case Presentation: A 42-year-old female with SLE presented with recurrent lower limb edema and dyspnea for 1 year, worsening over 2 weeks, followed by seizures. PD initiation alongside immunosuppressive therapy resolved neuropsychiatric symptoms and stabilized cardiorenal function. Proteomic Findings: PD fluid analysis showed significant down-regulation of complement-related proteins (FCER2 and CRP) on the fourth day after initiation of PD, suggesting PD attenuates neuroinflammation by targeted clearance of proinflammatory mediators. Conclusion: PD may serve as a viable adjunct therapy for NPSLE through modulation of complement overactivation.
Project description:We performed spatial transcriptomics on a case series of different clinical subtypes of cutaneous lupus erythematosus including acute cutaneous lupus erythematosus (malar rash, systemic lupus erythematosus). Our goals were to (1) determine which differentially expressed genes (DEGs) could be attributed to specific cell populations in specific locations within the tissue, (2) determine if spatial transcriptomics could better distinguish between CLE clinical subtypes than bulk RNA approaches and (3) examine potential cell-cell communication pathways within the skin lesions.
Project description:The gold standard for diagnosing lupus nephritis, one of the common symptoms of systemic lupus erythematosus, is an invasive procedure, a Renal biopsy. To overcome the risk of invasive methods, we constructed a spectral library using biological samples that can be obtained non-invasively and analyzed it using the SWATH-MS method, a quantitative proteomic analysis.
Project description:Gene expression profile studies have identified an interferon signature in whole blood or mononuclear cell samples from patients with systemic lupus erythematosus. This study was designed to determine whether specific lymphocyte and myeloid subsets freshly isolated from the blood of systemic lupus erythematosus patients demonstrated unique gene expression profiles compared to subsets isolated from healthy controls. Keywords: patient compared to control
Project description:Transcription profiling by array of human PBMCs from primary antiphospholipid syndrome and systemic lupus erythematosus patients and healthy controls
Project description:The role of gut microbiota dysbiosis in systemic lupus erythematosus (SLE) pathogenesis remains elusive. Here, we show that fecal microbiota transplantation (FMT) from healthy mice to lupus mice ameliorated lupus-like symptoms. Microbiota reconstitution effectively reduced systemic class switch recombination and elevated IGH naïve isotype. Microbiota profiling revealed an enrichment of Lactobacillus johnsonii post-FMT, with a significant correlation to purine metabolites. Importantly, the Lactobacillus johnsonii-derived inosine, an intermediate metabolite in purine metabolism, effectively alleviated lupus-like symptoms by impeding B cell differentiation and reducing renal B cell infiltration. We further demonstrated that inosine reprograms B cells through the ERK-HIF-1α signaling pathway. Overall, our study highlights the discovery of a novel microbial metabolite modulating autoimmunity and suggests its potential for innovative microbiome-based therapeutic approaches.
